Editor’s Note
**Editor’s Note:** The global home beauty device market is on a strong growth trajectory, projected to nearly triple by 2029. In response, JUBILEE International has introduced the JUBI Plasma Ion Beam Time Machine, leveraging cold plasma eSIP® technology to set a new standard in at-home beauty. The brand has also enlisted celebrity investors Gorden Huang and Nana Kou as ambassadors, signaling confidence in cold plasma and ultrasound innovations.
The global home beauty device market is projected to grow from $20.8 billion in 2024 to $26.5 billion in 2025, reaching $68.8 billion by 2029. Leveraging this market gap, Huifang Li, General Manager of JUBILEE International Biomedical Technology Co., Ltd., has developed the JUBI Plasma Ion Beam Time Machine using cold plasma eSIP® technology, redefining the technical threshold of home beauty technology. Celebrity couple Gorden Huang and Nana Kou, known for their investment acumen, are optimistic about the application of cold plasma and ultrasound technologies in the biomedical field and have recently accepted JUBILEE’s invitation to serve as brand ambassadors.
Huifang Li noted that JUBILEE’s investment in cold plasma biomedical technology stems from an unmet need: while medical aesthetic treatments are effective, consumers spend most of their time on home care; general beauty devices are convenient but often lack biomedical-grade technical validation and clear differentiation. JUBILEE’s strategy is to use cold plasma as a core technology to open new possibilities for skin application in home beauty.
This also marks a key difference from medical aesthetic devices. Medical aesthetic devices typically pursue high-intensity treatment effects and require professional operation; JUBILEE targets the “skin longevity” trend, entering the “post-treatment maintenance” and “daily home care” market, allowing consumers to sustain skin condition through technological tools whether for home care or after medical aesthetic procedures.
From the initial product development, JUBILEE has differentiated itself from the market by incorporating human trials at medical centers, patent portfolio, and mass production yield management, ensuring a scientific data-driven development logic for “safe and effective” products.
Simultaneously, JUBILEE has filed multiple invention and utility model patents in the United States, Japan, Taiwan, and other regions, including devices for treating user skin with plasma. These patented technologies control the temperature, energy, and parameters of cold plasma, protecting consumer safety and the core technology.
Regarding market prospects of interest to stakeholders, from home beauty and medical aesthetic clinics to future applications in acne, chronic wound care, intimate care, and personalized skin management, eSIP® technology has the potential to develop into a platform technology spanning consumer medical and professional biomedical applications. How JUBILEE will transform its core technology into a scalable, verifiable, and extendable growth curve is worth watching.